Evidence map›Paper›PMID 25354038›Full record

ArticlePloS one2014

Phospholipase D2 is involved in the formation of Golgi tubules and ArfGAP1 recruitment.

Narcisa Martínez-Martínez, Emma Martínez-Alonso, José Ballesta, José A Martínez-Menárguez

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Narcisa Martínez-MartínezDepartment of Cell Biology and Histology, Medical School, IMIB-Arrixaca, University of Murcia, Murcia, Spain.
Emma Martínez-AlonsoDepartment of Cell Biology and Histology, Medical School, IMIB-Arrixaca, University of Murcia, Murcia, Spain.
José BallestaDepartment of Cell Biology and Histology, Medical School, IMIB-Arrixaca, University of Murcia, Murcia, Spain.
José A Martínez-MenárguezDepartment of Cell Biology and Histology, Medical School, IMIB-Arrixaca, University of Murcia, Murcia, Spain.
Universidad de Murcia · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lipids and lipid-modifying enzymes play a key role in the biogenesis, maintenance and fission of transport carriers in the secretory and endocytic pathways. In the present study we demonstrate that phosphatidic acid generated by phospholipase D2 (PLD2) is involved in the formation of Golgi tubules. The main evidence to support this is: 1) inhibitors of phosphatidic acid formation and PLD2 depletion inhibit the formation of tubules containing resident enzymes and regulators of intra-Golgi transport in a low temperature (15°C) model of Golgi tubulation but do not affect brefeldin A-induced tubules, 2) inhibition of PLD2 enzymatic activity and PLD2 depletion in cells cultured under physiological conditions (37°C) induce the formation of tubules specifically containing Golgi matrix proteins, and, 3) over-expression of PLD2 induces the formation of a tubular network. In addition, it was found that the generation of this lipid by the isoenzyme is necessary for ArfGAP1 recruitment to Golgi membranes. These results suggest that both proteins are involved in the molecular mechanisms which drive the formation of different types of Golgi tubules.

Indexed as

GTPase-Activating ProteinsHeLa CellsHumansPhosphatidic AcidsPhospholipase DProtein Transporttrans-Golgi NetworkARFGAP1 protein, humanGTPase-Activating ProteinsPhosphatidic AcidsPhospholipase Dphospholipase D2

Identifiers

PMID25354038
PMCPMC4213061
OpenAlexW2138997984

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.